JunctuCell Biomed Manufacturing GmbH
Patent Applications and Registrations
Patent applications and USPTO patent grants for JunctuCell Biomed Manufacturing GmbH.The latest application filed is for "protection of the vascular endothelium from immunologically mediated cytotoxic reactions with human cd34-negative progenitor cells".
- JunctuCell Biomed Manufacturing GmbH - Hohenbrunn DE
| Patent | Date |
|---|---|
| Protection Of The Vascular Endothelium From Immunologically Mediated Cytotoxic Reactions With Human Cd34-negative Progenitor Cells App 20200289577 - EISSNER; Gunther ; et al. | 2020-09-17 |
| Genetically Modified Mesenchymal Stem Cells Expressing An Immune Response-stimulating Cytokine To Attract And/or Activate Immune App 20200268802 - Gunther; Christine ; et al. | 2020-08-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 